255 related articles for article (PubMed ID: 17804845)
1. Clinical practice. Hypertriglyceridemia.
Brunzell JD
N Engl J Med; 2007 Sep; 357(10):1009-17. PubMed ID: 17804845
[No Abstract] [Full Text] [Related]
2. Treating hypertriglyceridemia.
Röggla G; Fasan M; Kapiotis S
CMAJ; 2007 Sep; 177(6):603; author reply 604-5. PubMed ID: 17846444
[No Abstract] [Full Text] [Related]
3. Treating hypertriglyceridemia.
Yavasoglu I; Kadikoylu G; Bolaman Z
CMAJ; 2007 Sep; 177(6):603-4; author reply 604-5. PubMed ID: 17846443
[No Abstract] [Full Text] [Related]
4. Hypertriglyceridemia and cardiovascular disease management.
Codario RA
J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
[No Abstract] [Full Text] [Related]
5. Treating hypertriglyceridemia.
Holub BJ
CMAJ; 2007 Sep; 177(6):604; author reply 604-5. PubMed ID: 17846446
[No Abstract] [Full Text] [Related]
6. First-line therapies for lowering triglyceride levels.
Raghavan VA
Am Fam Physician; 2008 Feb; 77(4):416; author reply 417-8. PubMed ID: 18326158
[No Abstract] [Full Text] [Related]
7. Bridging the gap in treatment options for patients with hypertriglyceridemia.
Underberg JA; Hays R
J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
[TBL] [Abstract][Full Text] [Related]
8. Drugs for lipids.
Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
[No Abstract] [Full Text] [Related]
9. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
Alagona P
Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice. Low HDL cholesterol levels.
Ashen MD; Blumenthal RS
N Engl J Med; 2005 Sep; 353(12):1252-60. PubMed ID: 16177251
[No Abstract] [Full Text] [Related]
11. Management of hypertriglyceridemia.
Oh RC; Lanier JB
Am Fam Physician; 2007 May; 75(9):1365-71. PubMed ID: 17508532
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein.
Backes JM; Gibson CA
Ann Pharmacother; 2005 Mar; 39(3):523-6. PubMed ID: 15671087
[TBL] [Abstract][Full Text] [Related]
14. Current drug treatments for lipid management.
Stone NJ
Manag Care; 2002 Sep; 11(9 Suppl):4-9. PubMed ID: 12369341
[No Abstract] [Full Text] [Related]
15. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of dyslipidemia in clinical practice].
Paragh G; Harangi M
Orv Hetil; 2006 Mar; 147(9):389-94. PubMed ID: 16619956
[TBL] [Abstract][Full Text] [Related]
17. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
18. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
Naruszewicz M; Nowicka G; Szostak WB; Kłosiewicz-Latoszek L
Kardiol Pol; 1982; 25(7-8):527-31. PubMed ID: 7169740
[No Abstract] [Full Text] [Related]
19. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
20. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
Lal SM; Katyal A
Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
